ISRCTN58988083未知未知
Cardiovascular disease risk reduction in China: a pilot and clustered randomized controlled trial in Zhejiang
niversity of Leeds0 个研究点目标入组 28,130 人开始时间: 2012年10月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 28,130
研究概览
简要总结
2013 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/24160442 protocol 2017 Results article in https://pubmed.ncbi.nlm.nih.gov/28813512/ results (added 26/02/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Inclusion criteria as of 29/07/2016:
- •Township hospitals:
- •1. Have family doctors who provide care according to the essential public health tasks requested by the government and who agree to follow the allocated treatment
- •2. Are willing to participate in the trial or pilot study
- •High CVD risk subjects:
- •1. Adults aged 50-74 years who have provided informed consent
- •2. Have been diagnosed as hypertension with a calculated 10-year CVD risk of 20% or higher, or have a recorded medical history of diabetes
- •3. Hold permanent residency in the study area
- •Previous inclusion criteria as of 06/12/2012:
- •Township hospitals:
- •1. Have family doctors who provide care according to the essential public health tasks requested by the government and who agree to follow the allocated treatment
- •2. Are willing to participate in the trial or pilot study
- •High CVD risk subjects:
- •1. Adults aged 60 years and above who have provided informed consent
- •2. Hold permanent residency in the study area
- •3. Have a calculated 10-year CVD risk of 20% or higher
- •4. Have a recorded medical history of diabetes, hyperlipidaemia, coronary heart disease, ischaemic or haemorrhagic cerebro-vascular disease, or peripheral vascular disease.
- •Previous inclusion criteria until 06/12/2012:
- •Township hospitals:
- •1. Located in rural Zhejiang
- •2. Have family doctors who provide care according to the essential public health tasks requested by the government and who agree to follow the allocated treatment
- •3. Are willing to participate in the trial or pilot study
- •High CVD risk subjects:
- •1. Adults aged 40-74 years who have provided informed consent
- •2. Hold permanent residency in the study area
- •3. Have a calculated 10-year CVD risk of 20% or higher, including those having a recorded medical history of hypertension (>140/90)
- •4. Diabetes, hyperlipidaemia, coronary heart disease, ischaemic or haemorrhagiccerebro-vascular disease, or peripheral vascular disease, or those without CVD symptoms.
排除标准
- •Current exclusion criteria as of 06/12/2012:
- •1. People with known mental illnesses or other severe diseases or disabilities which mean they cannot communicate with township doctors well or regularly
- •2. Those not living in the community or will move away in the next two years
- •3. People who have shown serious adverse effects to the recommended drugs
- •4. Patients who decline to participate in the trial will be excluded
- •Previous exclusion criteria until 06/12/2012:
- •1. People with known mental illnesses or other severe diseases or disabilities which mean they cannot communicate with township doctors well or regularly
- •2. Those not living in the community or will move away in the next three years after recruitment
- •3. People who have shown serious adverse effects to the recommended drugs
- •4. Pregnant or breastfeeding women
- •5. Patients who decline to participate in the trial will be excluded
研究者
相似试验
已完成
不适用
China PEACE-Prospective 3-vessel Disease StudyCoronary Heart DiseaseNCT01625312China National Center for Cardiovascular Diseases2,339
尚未招募
不适用
Precision Medicine Study on Cardiovascular Disease (PRECISE)Cardiovascular DiseasesNCT04434911China National Center for Cardiovascular Diseases20,000
已完成
不适用
China PEACE-Prospective PCI StudyCoronary Heart DiseaseNCT01624922China National Center for Cardiovascular Diseases5,185
Unknown
不适用
China Diabetes Cardiovascular InitiativeDiabetes MellitusAcute Coronary SyndromeNCT05037058Beijing Institute of Heart, Lung and Blood Vessel Diseases9,600
已完成
不适用
China PEACE-Retrospective CathPCI StudyCoronary Heart DiseaseNCT01624896China National Center for Cardiovascular Diseases12,000